Fibrodysplasia Ossificans Progressiva (FOP) is an autosomal dominant skeletal disorder characterized by widespread and debilitating bone formation in place of soft connective tissue. All mutations associated with FOP map to the BMP type I receptor, ALK2, with the vast majority of patients possessing the ALK2R206H mutation which results in hyperactive signaling. Here, we show that human ALK2R206H exhibits hyperactive signaling both in Drosophila cell culture and in vivo. As true for ALK2R206H–induced signaling in vertebrates, we find that the increase in signaling is also ligand-independent in Drosophila. Using the Drosophila system to identify factors required for this hyperactivity, we identified the type II receptor as a key determinant for mutant ALK2R206H receptor signaling. In addition, we found that the wild-type ALK2 receptor can antagonize, as well as promote, BMP signaling. Due to the heterozygosity typical of FOP, this dual function is of particular interest given that the interplay between the two disparate behaviors of wild-type ALK2 could be shifted by the presence of the hyperactive ALK2R206H mutant receptors. We present our work as a compelling example for the use of Drosophila as a model organism to study the molecular underpinnings of a complex human syndrome such as FOP.